Ftse Mib
33.707,21
0,00%
DAX
18.162,53
0,00%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.599,96
-0,34%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Augmedix Inc (AUGX) Augmedix Inc (AUGX) Notizie

Augmedix Inc

AUGX
0,8489
-0,0041 (-0,48%)
26 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/6/202418:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/6/202413:00GLOBEEmergency Services Inc. Partners with Augmedix to Introduce..
19/6/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:00GLOBEAugmedix Reiterates Second Quarter and Full Year 2024..
29/5/202413:00GLOBEAugmedix Appoints Alex Stinard, M.D., as Chief Clinical AI..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:09EDGAR2Form 8-K - Current report
13/5/202422:03GLOBEAugmedix Delivers 40% Revenue Growth for First Quarter of..
03/5/202413:00GLOBEAugmedix to Participate in Upcoming Investor Conferences in..
30/4/202413:00GLOBEAugmedix to Announce First Quarter 2024 Financial Results on..
25/4/202422:05GLOBEAugmedix Awarded on Newsweek’s World’s Best Digital Health..
24/4/202413:00GLOBEAugmedix Launches Industry’s First Fully-Automated,..
09/4/202413:00GLOBEAugmedix Integrates with Andor Health to Revolutionize..
04/4/202413:00GLOBEAugmedix and SADA Forge Partnership to Scale Ambient..
19/3/202412:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
18/3/202421:01GLOBEAugmedix Delivers 45% Revenue Growth and Expanded Gross..
12/3/202412:00GLOBEAugmedix Announces New Positive Data and Enhancements to Its..
08/3/202413:00GLOBEAugmedix to Announce Fourth Quarter and Full Year 2023..
05/3/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202413:00GLOBEAugmedix to Participate in Citizens JMP Technology..
13/2/202413:00GLOBEAugmedix Names Tomer Levy as New Senior Vice President of..
09/2/202420:14EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202422:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
16/1/202413:00GLOBEAugmedix Announces Participation in Maxim Group Virtual..
09/1/202422:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202422:05EDGAR2Form 8-K - Current report
05/1/202422:05EDGAR2Form 8-K - Current report
05/1/202414:00GLOBEAugmedix Exits Calendar 2023 with Expected $51 Million in..
20/12/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202316:29PRNUSAugmedix Partners with Google Cloud to Bring Medically-Tuned..
13/12/202316:05GLOBEAugmedix Partners with Google Cloud to Bring Medically-Tuned..
29/11/202323:11EDGAR2Form 8-K - Current report
27/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202313:00GLOBEAugmedix Announces Closing of Public Offering of Common..
20/11/202322:05EDGAR2Form 8-K - Current report
17/11/202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202306:15GLOBEAugmedix Announces Pricing of Upsized Public Offering of..
15/11/202323:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 0,8494 Min: 0,8235 Max: 0,9258
Chiusura: 0,853

La tua Cronologia

NASDAQ
AUGX
Augmedix
COIN
TELOSETH
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network